The Current Ratio as of December 2024 (TTM) for Shionogi & Co., Ltd. (SGIOF) is 7.07

According to Shionogi & Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 7.07. This represents a change of 9.94% compared to the average of 6.43 of the last 4 quarters.

Shionogi & Co., Ltd. (SGIOF) Historical Current Ratio (quarterly & annually)

How has SGIOF Current Ratio performed in the past?

The mean historical Current Ratio of Shionogi & Co., Ltd. over the last ten years is 5.06. The current 7.07 Current Ratio has changed 13.87% with respect to the historical average. Over the past ten years (40 quarters), SGIOF's Current Ratio was at its highest in in the September 2020 quarter at 7.80. The Current Ratio was at its lowest in in the March 2017 quarter at 3.79.

Shionogi & Co., Ltd. (SGIOF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Shionogi & Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shionogi & Co., Ltd. (SGIOF) Average Current Ratio

How has SGIOF Current Ratio performed in the past?

The current Current Ratio of Shionogi & Co., Ltd. (SGIOF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Shionogi & Co., Ltd. (SGIOF) Current Ratio vs. Peers

How is SGIOF’s Current Ratio compared to its peers?

Shionogi & Co., Ltd.’s Current Ratio is greater than Taisho Pharmaceutical Holdings Co., Ltd. (5.16), greater than Vivesto AB (5.95), greater than Acorda Therapeutics, Inc. (0.22), greater than Pacira BioSciences, Inc. (2.25), less than Shionogi & Co., Ltd. (7.07), greater than Sunshine Biopharma, Inc. (5.74), greater than Alimera Sciences, Inc. (2.79), greater than China SXT Pharmaceuticals, Inc. (1.60), less than Guardion Health Sciences, Inc. (16.67), greater than Cresco Labs Inc. (1.97), greater than Curaleaf Holdings, Inc. (1.11), greater than Trulieve Cannabis Corp. (4.41), greater than Journey Medical Corporation (1.38), greater than Aurora Cannabis Inc. (3.42), greater than Ironwood Pharmaceuticals, Inc. (3.62), greater than Assertio Holdings, Inc. (2.01), greater than Neurocrine Biosciences, Inc. (4.37), greater than Deciphera Pharmaceuticals, Inc. (4.19), greater than Esperion Therapeutics, Inc. (1.85),

Build a custom stock screener for Shionogi & Co., Ltd. (SGIOF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shionogi & Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shionogi & Co., Ltd. (SGIOF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shionogi & Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.